GlassScriptPhysician profile
Nadezhda Krasik
NPI 1467009134
$1,452.72
in general payments reported to CMS, 2019-2025
14 companies · $612 in 2025
The $612 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $286 · 2024: $554 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $476.72 | 2023-2025 | Repatha, Repatha, Evenity |
| Abbvie INC. | $278.58 | 2024 | |
| Astellas Pharma US INC | $191.94 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $127.43 | 2023-2025 | Cologuard Collection Kit |
| Phadia US INC. | $84.20 | 2023 | Immunocap |
| Novo Nordisk INC | $62.71 | 2024-2025 | Wegovy |
| Pfizer INC. | $53.28 | 2023-2025 | |
| Dexcom, INC. | $47.52 | 2024 | Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $37.66 | 2024-2025 | Crysvita |
| Visby Medical, INC. | $22.22 | 2024 | Visby Medical Respiratory Health Test, Visby Medical Sexual Health Click Test |
| Abbott Laboratories | $20.02 | 2024 | Id Now Instrument |
| Aimmune Therapeutics, INC. | $19.17 | 2024 | |
| Lilly USA, LLC | $18.00 | 2024 | Mounjaro |
| Kowa Pharmaceuticals America, INC. | $13.27 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadezhda Krasik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.